SAIF: Sacroiliac Fusion Study
Status: | Recruiting |
---|---|
Conditions: | Orthopedic |
Therapuetic Areas: | Orthopedics / Podiatry |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 3/26/2016 |
Start Date: | February 2014 |
End Date: | December 2016 |
Contact: | Lisa Ingham |
Email: | lingham@zyga.com |
SAIF: Sacroiliac Fusion Study Using the Zyga SImmetry Sacroiliac Joint Fusion System
The purpose of the SAIF study is to evaluate the SImmetry Sacroiliac Joint Fusion System for
fusion and pain reduction of the SI joint.
fusion and pain reduction of the SI joint.
This is a prospective, non-randomized, single center study to collect data on fusion and
pain reduction following implantation of the SImmetry device. Up to 15 total subjects will
be implanted and followed for 24 months. Data will be collected pre-operatively, at implant,
discharge, and at specified follow-up time points (6 weeks, 3 months, 6 months, 12 months,
24 months.)
pain reduction following implantation of the SImmetry device. Up to 15 total subjects will
be implanted and followed for 24 months. Data will be collected pre-operatively, at implant,
discharge, and at specified follow-up time points (6 weeks, 3 months, 6 months, 12 months,
24 months.)
Inclusion Criteria:
- Subjects must be indicated for the SImmetry device according to the approved SImmetry
labeling
- Subject has three (3) positive (experiences pain) Provocative Tests for SIJ pain; for
example, Compression, Thigh Thrust, FABER, Distraction or Gaenslen's
- Subject has documentation of failed, non-operative management of SIJ pain for ≥ 6
months prior to surgery; for example, use of medications, braces, SI belts,
orthotics, physical therapy or manual manipulation
- The subject has one (1) positive diagnostic SIJ injection, resulting in a ≥50%
decrease in pain from the anesthetic portion of the injection
- The subject has VAS back pain score of ≥ 60 mm
- The subject has an ODI ≥ 40%
- The subject is at least 18 years of age and skeletally mature
- The subject agrees and is able to comply with study requirements
Exclusion Criteria:
- Subjects contraindicated per the cleared labeling will be excluded from participation
in the study
- The subject has pelvic soft tissue or bony tumors
- The subject has had any trauma causing fracture of the sacrum or iliac bones or has
had spinal trauma leading to a neurological deficit
- The subject has a history of a central nervous system (CNS) disorder(s)
- The subject is pregnant or is planning on becoming pregnant in the next two years
- The subject has chemical dependency problems as evidenced by a history of drug abuse
which is documented in their past medical history or is elicited from an interview
- The subject has a history of significant emotional or psychosocial disturbance
(anxiety attacks, obsessive/compulsive disorders, depression or schizophrenia) as
documented in their past medical history or elicited by an interview
We found this trial at
1
site
Click here to add this to my saved trials